tradingkey.logo

Tempus AI Inc

TEM

55.180USD

+0.750+1.38%
Close 05/30, 16:00ETQuotes delayed by 15 min
9.55BMarket Cap
LossP/E TTM

Tempus AI Inc

55.180

+0.750+1.38%
More Details of Tempus AI Inc Company
Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. The Company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Its product lines include genomics, data, and artificial intelligence applications (AI). Its genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction (PCR), profiling, molecular genotyping, and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.
Company Info
Company codeTEM
Company nameTempus AI Inc
IPO dateJun 14, 2024
Founded at2015
CEOMr. Eric P. Lefkofsky
Number of employees2400
Security typeOrdinary Share
Fiscal year-endJun 14
Address600 West Chicago Avenue
CityCHICAGO
Stock exchangeNASDAQ Global Select Consolidated
CountryUnited States of America
Postal code60654
Phone18009765448
Websitehttps://www.tempus.com/
Company codeTEM
IPO dateJun 14, 2024
Founded at2015
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Eric P. Lefkofsky
Mr. Eric P. Lefkofsky
Chief Executive Officer, Director
Chief Executive Officer, Director
4.55M
-29.22%
Mr. Ryan Fukushima
Mr. Ryan Fukushima
Chief Operating Officer
Chief Operating Officer
912.28K
-2.96%
Barris (Peter J)
Barris (Peter J)
Independent Director
Independent Director
104.02K
+1.96%
Mr. Eric D. Belcher
Mr. Eric D. Belcher
Independent Director
Independent Director
16.70K
+13.58%
Mr. Andrew (Andy) Polovin
Mr. Andrew (Andy) Polovin
Executive Vice President, General Counsel
Executive Vice President, General Counsel
12.87K
-72.80%
Mr. James (Jim) Rogers
Mr. James (Jim) Rogers
Chief Financial Officer
Chief Financial Officer
5.48K
-75.79%
Mr. David R. Epstein
Mr. David R. Epstein
Independent Director
Independent Director
5.42K
+42.85%
Dr. Scott Gottlieb, M.D.
Dr. Scott Gottlieb, M.D.
Independent Director
Independent Director
3.25K
+159.76%
Dr. Wayne A.I. Frederick, M.D.
Dr. Wayne A.I. Frederick, M.D.
Independent Director
Independent Director
--
--
Mr. Theodore John (Ted) Leonsis
Mr. Theodore John (Ted) Leonsis
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Eric P. Lefkofsky
Mr. Eric P. Lefkofsky
Chief Executive Officer, Director
Chief Executive Officer, Director
4.55M
-29.22%
Mr. Ryan Fukushima
Mr. Ryan Fukushima
Chief Operating Officer
Chief Operating Officer
912.28K
-2.96%
Barris (Peter J)
Barris (Peter J)
Independent Director
Independent Director
104.02K
+1.96%
Mr. Eric D. Belcher
Mr. Eric D. Belcher
Independent Director
Independent Director
16.70K
+13.58%
Mr. Andrew (Andy) Polovin
Mr. Andrew (Andy) Polovin
Executive Vice President, General Counsel
Executive Vice President, General Counsel
12.87K
-72.80%
Mr. James (Jim) Rogers
Mr. James (Jim) Rogers
Chief Financial Officer
Chief Financial Officer
5.48K
-75.79%
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholder
Update time: Sat, May 17
Update time: Sat, May 17
Shareholder Statistics
Type
Shareholder Statistics
Shareholder
Proportion
Blue Media, LLC
15.37%
BK TL21 LLC
9.05%
Baillie Gifford & Co.
7.31%
Red Sky LLC
5.65%
Gray Media, LLC
5.60%
Other
57.02%
Shareholder Statistics
Shareholder
Proportion
Blue Media, LLC
15.37%
BK TL21 LLC
9.05%
Baillie Gifford & Co.
7.31%
Red Sky LLC
5.65%
Gray Media, LLC
5.60%
Other
57.02%
Type
Shareholder
Proportion
Corporation
35.67%
Investment Advisor
18.59%
Investment Advisor/Hedge Fund
9.65%
Individual Investor
4.40%
Holding Company
3.22%
Research Firm
2.89%
Venture Capital
2.48%
Hedge Fund
2.40%
Sovereign Wealth Fund
0.62%
Other
20.09%
Institutional Shareholding
Update time: Tue, Mar 4
Update time: Tue, Mar 4
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
355
133.77M
79.59%
-1.99M
2024Q4
259
141.87M
89.45%
+26.80M
2024Q3
171
136.39M
89.94%
+26.38M
2024Q2
115
132.44M
88.72%
+132.44M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Blue Media, LLC
26.59M
15.83%
-1.03M
-3.73%
Feb 21, 2025
BK TL21 LLC
15.22M
9.06%
-1.34M
-8.10%
Feb 21, 2025
Baillie Gifford & Co.
13.75M
8.19%
+4.38M
+46.81%
Sep 30, 2024
Red Sky LLC
11.56M
6.88%
-5.00M
-30.22%
Dec 31, 2024
Gray Media, LLC
9.56M
5.69%
-50.00K
-0.52%
Feb 21, 2025
ARK Investment Management LLC
5.52M
3.29%
+3.14M
+132.10%
Dec 31, 2024
SoftBank Group Corp
5.41M
3.22%
--
--
Dec 31, 2024
Lefkofsky (Eric Paul)
6.43M
3.83%
+238.43K
+3.85%
Feb 21, 2025
Nikko Asset Management Co., Ltd.
3.24M
1.93%
+2.02M
+166.00%
Dec 31, 2024
View more
Related ETFs
Update time: Tue, May 6
Update time: Tue, May 6
Name
Proportion
ARK Genomic Revolution ETF
7.19%
ARK Innovation ETF
3.7%
Renaissance IPO ETF
3.7%
ROBO Global Artificial Intelligence ETF
2.01%
KraneShares Artificial Intelligence and Tcnlgy ETF
1.91%
ROBO Global Healthcare Technology & Innovation ETF
1.54%
AXS Green Alpha ETF
1.48%
First Trust Nasdaq AI and Robotics ETF
1.36%
Franklin Genomic Advancements ETF
1%
Invesco Nasdaq Biotechnology ETF
0.85%
View more
ARK Genomic Revolution ETF
Proportion7.19%
ARK Innovation ETF
Proportion3.7%
Renaissance IPO ETF
Proportion3.7%
ROBO Global Artificial Intelligence ETF
Proportion2.01%
KraneShares Artificial Intelligence and Tcnlgy ETF
Proportion1.91%
ROBO Global Healthcare Technology & Innovation ETF
Proportion1.54%
AXS Green Alpha ETF
Proportion1.48%
First Trust Nasdaq AI and Robotics ETF
Proportion1.36%
Franklin Genomic Advancements ETF
Proportion1%
Invesco Nasdaq Biotechnology ETF
Proportion0.85%
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI